MicroRNA-362-5p Promotes Tumor Growth and Metastasis by Targeting CYLD in Hepatocellular Carcinoma.

Fang Ni,Hua Zhao,Huaqin Cui,Zhengsheng Wu,Li Chen,Zhongqian Hu,Chuang Guo,Yakun Liu,Zhuo Chen,Xinyi Wang,Danlei Chen,Haiming Wei,Siying Wang
DOI: https://doi.org/10.1016/j.canlet.2014.10.041
IF: 9.756
2015-01-01
Cancer Letters
Abstract:•MiR-362-5p is frequently up-regulated in hepatocellular carcinoma (HCC) and associated with HCC progression.•Inhibition of miR-362-5p significantly decreases HCC cell proliferation, clonogenicity, migration, and invasion in vitro.•Inhibition of miR-362-5p dramatically suppresses HCC tumor growth and metastasis in vivo.•MiR-362-5p targets CYLD through its 3′-UTR in HCC cells.•MiR-362-5p acts through CYLD to activate the NF-κB signaling pathway, which contributes to HCC progression.
What problem does this paper attempt to address?